This paper is in the following e-collection/theme issue:

Reviews in Medical Informatics (110) Computer-Aided Diagnosis (243) Digital Biomarkers and Digital Phenotyping (278) Diagnostic Tools in Mental Health (322) Dementia and Cognitive Decline (687) Extended Reality, Virtual Reality and Virtual Worlds (752) Artificial Intelligence (2089)

Published on in Vol 13 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/62914, first published .
Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review

Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review

Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review

Authors of this article:

María de la Paz Scribano Parada1, 2, 3 Author Orcid Image ;   Fátima González Palau1, 4, 5 Author Orcid Image ;   Sonia Valladares Rodríguez6, 7 Author Orcid Image ;   Mariano Rincon7 Author Orcid Image ;   Maria José Rico Barroeta4 Author Orcid Image ;   Marta García Rodriguez4 Author Orcid Image ;   Yolanda Bueno Aguado4 Author Orcid Image ;   Ana Herrero Blanco4 Author Orcid Image ;   Estela Díaz-López7 Author Orcid Image ;   Margarita Bachiller Mayoral7 Author Orcid Image ;   Raquel Losada Durán4 Author Orcid Image
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Garcia-Navarra S, Solares L, Mendez M. Virtual reality and mixed reality in the assessment of spatial memory. Exploration of Digital Health Technologies 2025;3 View
  2. Dall’Ora N, Felli L, Aldegheri S, Vicino N, Giuliano R. LumiCare: A Context-Aware Mobile System for Alzheimer’s Patients Integrating AI Agents and 6G. Electronics 2025;14(17):3516 View
  3. Mulet i Piera X, Del Campo-Montoya R, Cuadrado-Tejedor M, Garcia-Osta A, Garbayo E, Blanco-Prieto M. Intranasal delivery of lipid-based nanoparticles for the treatment of neurodegenerative diseases: advances, challenges and future perspectives. Expert Opinion on Drug Delivery 2025:1 View